Capital volume
CHF 27.1 million

Number of shares
1,000,000 new bearer shares with nominal value CHF 0.10 each

Issue price
CHF 27.10 each share

Subscription deadline
By Thursday, April 30, 2020 with enclosed subscription form

Minimum subscription
500 shares / CHF 13,550

Decision of the Board of Directors in consideration of subscription rights

By Thursday, April 30, 2020 to the escrow account of InnoMedica Holding AG at UBS Switzerland AG (IBAN: CH03 0023 5235 2621 75D7 L)

Ms Andrea Zurkirchen, phone: +41 (0)44 383 88 22,

Public offer
View publication at SHAB website

Investor events
Due to the current corona situation, investor events are held online. Pre-register here.

Please find below the relevant investor documents (including subscription form). Information on InnoMedica and the projects TaliCoVax-19 (vaccination), Talidox (oncology) and Talineuren (neurology) can be found in the business documentation.

Investor documentation

Download last year's documents